CIK 0001801170 · Large accelerated filer
CLOVER HEALTH INVESTMENTS, CORP. /DE
Sign in to watch- Ticker
- CLOV
- Exchange
- Nasdaq
- Industry
- Hospital & Medical Service Plans
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 981515192
- Phone
- (201) 432-2133
- Business address
- 30 MONTGOMERY STREET, JERSEY CITY, NJ, 07302
- Former names
- Social Capital Hedosophia Holdings Corp. III
- 4 Grant or award Chief Accounting Officer acquired 186,403 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 328,947 shares (grant or award)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change
- 4 Planned sale Chief Legal Officer sold 19,275 shares at $4.66 ($89,822)
- 4 Planned sale CEO, Medicare Advantage sold 4,066 shares at $4.41 ($17,931)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Executive Officer sold 62,176 shares at $4.68 ($290,984)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Legal Officer sold 14,673 shares at $4.68 ($68,670)
- 4 Planned sale Interim CFO sold 4,591 shares at $4.68 ($21,486)
- 4 Planned sale CEO, Counterpart Health sold 23,627 shares at $4.68 ($110,574)
- 4 Planned sale CEO, Medicare Advantage sold 18,273 shares at $4.68 ($85,518)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Regulation FD disclosure
- 4 Planned sale CEO, Medicare Advantage sold 2,006 shares at $4.63 ($9,288)
Page 1 of 36 · 711 filings